CIK 0001841330 · <br>Emerging growth company
Pasithea Therapeutics Corp.
Sign in to watch- Ticker
- KTTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851591963
- Phone
- (702) 514-4174
- Business address
- 1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-K/A Report 10-K/A
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Delisting notice
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Shareholder vote results · Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- DFAN14A Other Proxy Soliciting Materials
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- DEFA14A Proxy Proxy Materials
Page 10 of 18 · 344 filings